Skip to main content
Company record · Bruxelles
Belgian companySituation normaleSociété à responsabilité limitée

Bioeast Nexus

Enterprise number
1025.277.924
VAT number
BE1025277924
Registered office
Square de Meeûs 35, 1000 Bruxelles
See the 249 companies at this address
Incorporated on
8 July 2025
Latest financial year
2025
m87-f model
Size
Not published
Workforce not declared
Equity
-€2.5K
Financial year 2025
Net result
-€6.5K
Financial year 2025

Profile

Official information from the CBE (FPS Economy).

Bioeast Nexus is a Belgian company (Société à responsabilité limitée) whose registered office is established at 1000 Bruxelles, inside the business centre Silversquare. Its main activity falls under “Activités de conseil pour les affaires et autre conseil de gestion” (NACE 70200).

Legal form
Société à responsabilité limitée
Legal situation
Situation normale
Date of incorporation
8 July 2025

Domiciliation

Business centre hosting this company's registered office.

Silversquare
silversquare.eu240 entities at this address
See the centre

Anti-money-laundering (AML) compliance

Is this activity subject to the Belgian anti-money-laundering obligations? An indicative assessment based on the declared NACE code.

Conditional obligationCompany service provider (potential)

Given its declared activity (“Activités de conseil pour les affaires et autre conseil de gestion”), Bioeast Nexus may be subject to anti-money-laundering obligations, under the conditions below.

Some business services fall under company service providers, which are obliged entities.

Conditions: Covered if the company professionally provides third parties with one of these services: taking part in the purchase or sale of shares in a company (other than a listed one), providing a statutory seat, or providing a commercial, postal or administrative address and related services (registered office). The AMLR (EU) 2024/1624 will widen this perimeter on 10 July 2027 (company formation, director mandates, nominee arrangements).

Applicable obligations
  • Identification and verification of the client's identity (KYC)
  • Identification of the ultimate beneficial owners (UBO register)
  • Assessment of money-laundering and terrorist-financing risks
  • Ongoing diligence and monitoring of transactions
  • Reporting suspicions to the CTIF
  • Retention of the documents and appointment of an AMLCO

Legal basis: art. 5, §1, 29° of the Act of 18 September 2017, referring to art. 3, 1° of the Act of 29 March 2018.

General information based on the declared NACE activity code; it is not legal advice. Whether the obligations actually apply depends on the activity effectively carried out.

Your risk analysis on this company

AML Company ran Bioeast Nexus through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Establishments

1 active establishment unit declared with the CBE.

Implantation
Bruxelles

1 establishment · 1 municipality

Registered office1 establishment
Registered office
Square de Meeûs 35
Map
Establishment2379.718.618
Square de Meeûs 35
Map

Finances & financial health

Multi-year summary extracted from the annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium).

Financial trend

Equity & result

EquityResult
Key figures by financial year
Financial yearEquityResult
2025-€2,474-€6,474

Financial ratios

Solvency, liquidity and profitability, computed year by year from the filed annual accounts.

Solvency
-87%
Financial year 2025

Equity / balance sheet total

Liquidity
0,31 x
Financial year 2025

Current assets / debts due within one year

Net margin
-

This year's filing does not carry the item the calculation needs.

Result for the year / turnover

Operating margin
-

This year's filing does not carry the item the calculation needs.

Operating result / turnover

Long-term debt
-

This year's filing does not carry the item the calculation needs.

Debts due after one year / balance sheet total

Return on equity
-

The filed denominator is zero or negative: the ratio would carry no meaning.

Result for the year / equity

Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.

Filing history (1)
Financial yearFilingFiling typeModelSource
08/07/202531/12/202524/06/2026Initialm87-fBNB

Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

Frequently asked questions about Bioeast Nexus

Quick answers on Bioeast Nexus's identity, contact details and official CBE information.

What is Bioeast Nexus's enterprise number (CBE)?
Bioeast Nexus's official enterprise number with the Crossroads Bank for Enterprises (CBE) is 1025277924. This unique number identifies the company with every Belgian administration.
What is Bioeast Nexus's VAT number?
Bioeast Nexus's intra-Community VAT number is BE1025277924. It is the CBE number prefixed with “BE” and enables trade within the European Union.
Where is Bioeast Nexus's registered office?
Bioeast Nexus's registered office is located at Square de Meeûs 35, 1000 Bruxelles, Belgium. This address is the official one declared with the CBE.
What is Bioeast Nexus's legal form?
Bioeast Nexus is incorporated under the legal form “Société à responsabilité limitée”. This form determines its legal and tax regime and its publication duties towards the Belgian Official Gazette.
When was Bioeast Nexus incorporated?
Bioeast Nexus was entered in the Crossroads Bank for Enterprises on 8 July 2025. This date is the official start of activity declared with the CBE.
Is Bioeast Nexus still active?
Yes, Bioeast Nexus is currently listed as an active company with the Crossroads Bank for Enterprises (CBE).
What is Bioeast Nexus's main activity?
Bioeast Nexus's declared main activity is: Activités de conseil pour les affaires et autre conseil de gestion (NACE code 70200). This NACE code officially classifies the company in the European nomenclature of economic activities.
How many establishments does Bioeast Nexus have?
Bioeast Nexus declares 1 establishment unit registered with the CBE, on top of its registered office.
Has Bioeast Nexus filed its annual accounts?
Yes. Bioeast Nexus's latest annual accounts were filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) on 24 June 2026, for the financial year ended 31 December 2025. The filings can be consulted publicly with the NBB.
Which official notices concern Bioeast Nexus?
1 official notice about Bioeast Nexus is available in the Belgian Official Gazette: incorporation, changes to the articles, appointments, dissolutions. Every one of these acts is listed on this page with a link to the official PDF.
Is Bioeast Nexus subject to anti-money-laundering obligations in Belgium?
It depends on the activity actually carried out. Bioeast Nexus (Company service provider (potential)) may be subject to anti-money-laundering obligations under certain conditions: Covered if the company professionally provides third parties with one of these services: taking part in the purchase or sale of shares in a company (other than a listed one), providing a statutory seat, or providing a commercial, postal or administrative address and related services (registered office). The AMLR (EU) 2024/1624 will widen this perimeter on 10 July 2027 (company formation, director mandates, nominee arrangements)..

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
2 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2026
    1. 24 June 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m87-fFiled accounts2026-00228496
  2. 2025
    1. 10 July 2025IncorporationView the notice25344306

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, anonymised audience-measurement cookies (hosted in the EU) to improve our services. Learn more.